In searching for macromolecular antitumor antibiotics of microbial origin, 2,875 kinds of Actinomycetes culture fluids were applied to a newly developed test system which consisted of antimicrobial assay using a macromolecule permeable mutant, DNA damage assay and mutagenicity test. As a result, 78 macromolecular antibiotics were found. Among them, 15 antibiotics precipitable with ammonium sulfate were macromolecular peptide antibiotics (protein antibiotics), of which molecular weight ranged from 10,000 to 14,000.
Macromolecular peptide antibiotics AN-1, -5 and -15, termed type I antibiotics, showed stronger growth inhibitory effect on the uvrA and recA mutants, as compared to the effect on their parent, MP2. They also had mutagenic activity. , and -26, termed type 11, exhibited an increased inhibitory activity to a recA mutant but did not to an uvrA mutant. They all showed mutagenicity. AN-3, -11 and -13, type III antibiotics, gave similar influence on the DNA repair mutants, and on their parent, MP2. They had no mutagenic activity. Except for AN-11 and -13 of type III antibiotics, all antibiotics were inhibitory to the cell growth of a cancer cell, L1210. Our previous paper1) described a novel microbial system that was applicable to the screening of macromolecular antitumor antibiotics of microbial origin. The system consisted of 1) the system for isolation of macromolecular antibiotics based on macromolecule permeable property of a mutant, MP22,3), derived from Escherichia coli K-12, 2) the system to detect inhibitor of DNA synthesis employing DNA repair mutants derived from MP2 and 3) the system to detect mutagenic activity of newly isolated antibiotics using a valine sensitive strain of MP2, whose conversion rate to valine resistance was dependent on mutagenic activity.
In this paper, the newly established test system was applied for screening of macromolecular peptide antibiotics producing Actinomycetes. As a result, 15 kinds of macromolecular peptide antibiotics were newly discovered. Among them, 13 samples showed inhibitory effect on the in vitro cell growth of a cancer cell, L1210.
Materials and Methods

Microorganisms
Escherichia coli K-12 W3876 and its macromolecule permeable mutant, MP2, were employed for the detection of macromolecular antibiotics. REC9, UV28, UR3 and L7 were derived from MP2 and described in the preceding paper1).
A number of Actinomycetes were newly isolated from various soil samples.
Cultivation of Actinomycetes
Actinomycetes were cultivated at 29°C in shake flasks. The culture media used were described in * Present address: Central Research Laboratories , Ajinomoto Co., Kawasaki, Kanagawa, Japan. 
Determination of Antibacterial Activity
Quantitative determination of antibacterial activity was done by the disk assay using UR31). The diameter of inhibition zone was proportional to the logarithm of antibacterial activity. One unit of antibacterial activity was defined as the antibiotic concentration to give 10 mm (diameter) of inhibition zone.
Cell Culture of L1210 In order to examine antitumor activity of newly isolated antibiotics, their inhibitory effect on the growth of cancer cells was examined. A cancer cell, L1210 was cultured in Eagle minimum essential medium supplemented with 10% calf serum, 5 µg/ml of cefazolin and 100 ug/ml of streptomycin at 37°C in a 7 % CO2 incubater. Analysis Molecular weight of macromolecular peptide antibiotics was determined by chromatography on a column (1.5 x 30 cm) of Bio-Gel P30 using 0.02 M phosphate buffer containing 0.1 M NaCl (pH 7.0) as an eluting buffer (flow rate was 0.05 ml/minute). Blue dextran 2,000, myoglobin (MW 17,600), cytochrome C (MW 12,500) and bacitracin (MW 1,400) were used as standard.
BIURET, ninhydrin and anthrone reactions were done by the method of WESTLEY and LAMBETH4), BLACKBURN5) and SPIRO6), respectively.
Results
Screening of Macromolecular Antibiotics
Culture fluids of various Actinomycetes were subjected to the macromolecular antibiotic detecting system in which macromolecule permeable mutant MP2 was employed. As reported in the preceding paper, among 2,875 samples tested 78 samples showed strong growth inhibitory effect on MP21). Therefore, the molecular weight of these antibiotics seemed to be more than 1,200. Furthermore, active fractions of 15 out of 78 samples were precipitated from culture fluids by saturating with ammonium sulfate. These 15 samples were chosen as macromolecular peptide antibiotics to be investigated further in detail.
DNA Damage Assay and Mutagenicity Test for 15 Antibiotics
The 15 newly isolated antibiotics were subjected to both DNA damage assay and mutagenicity test, and classified into three groups as shown in Table 2 . An uvrA mutant, UV28 was more sensitive to DNA binding antibiotics such as actinomycin D, mitomycin C and adriamycin as compared to its parental strain MP21). On the other hand, a recA mutant of MP2, REC9 became more sensitive not only to the DNA binding antibiotics but also to the DNA degrading antibiotics such as neocarzinostatin type II showed prominent activity in that the antibiotic concentration giving 50% growth inhibition was as low as 0.25 unit/ml. Two samples, AN-11 and -13 out of three antibiotics of type III had no effect on growth of L1210. However, AN-3 of type III showed marked inhibitory effect on the growth of L1210 cells. 
